HALO Competitors
Halozyme Therapeutics, Inc.
$116.82
+$7.20(+6.57%)
62
Overall
60
Value
63
Tech
65
Quality
Market Cap
$13.26B
Volume
3.75M
52W Range
$61.23 - $116.85
Target Price
$101.30
HALO competitors: MNKD, LLY, BAX, PFE, SNY. Halozyme Therapeutics, Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
HALO Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| MNKD MannKind Corporation | $3.02 | $980.71M | $-0.20 | - | 24 |
| LLY Eli Lilly and Company | $1208.74 | $1.14T | $36.19 | 0.55% | 60 |
| BAX Baxter International Inc. | $24.80 | $12.82B | $2.04 | 0.16% | 61 |
| PFE Pfizer Inc. | $29.21 | $166.49B | $2.96 | 5.89% | 70 |
| SNY Sanofi | $39.77 | $95.41B | $5.00 | 6.08% | 60 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HALO | $116.82 | +6.6% | 3.75M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Halozyme Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW